Gentilly AND (oncology OR urology) - Exploration (Accueil)

Index « AffRegion.i » - entrée « Région Normandie »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Région Centre < Région Normandie < Région de Kantō  Facettes :

List of bibliographic references indexed by Région Normandie

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000002 (2023) Virginie Prevost [France] ; Titi Tran [France] ; B Xe9 N Xe9 Dicte Clarisse [France] ; Alexandra Leconte [France] ; Nathalie Duchange [France] ; Gr Xe9 Goire Moutel [France] ; Myl Xe8 Ne Gouriot [France]Shared Meditation Involving Cancer Patients, Health Professionals and Third Persons: Perceptions of Participants Through a Focus Group Study.
000011 (2022) Virginie Prevost [France] ; Sophie Lefevre-Arbogast [France] ; Alexandra Leconte [France] ; Claire Delorme [France] ; Sandrine Benoit [France] ; Titi Tran [France] ; B Xe9 N Xe9 Dicte Clarisse [France]Shared meditation involving cancer patients, health professionals and third persons is relevant and improves well-being: IMPLIC pilot study.
000015 (2022) Florence Joly [France] ; Michel Fabbro [France] ; Dominique Berton [France] ; Justine Lequesne [France] ; Am Xe9 Lie Anota [France] ; Alicja Puszkiel [France] ; Anne Floquet [France] ; H Xe9 L Xe8 Ne Vegas [France] ; Hugues Bourgeois [France] ; Le Xef La Bengrine Lefevre [France] ; Beno Xee T You [France] ; Fanny Pommeret [France] ; Alain Lortholary [France] ; Dominique Spaeth [France] ; Anne-Claire Hardy-Bessard [France] ; Cyril Abdeddaim [France] ; Marie-Christine Kaminsky-Forrett [France] ; Michel Tod [France] ; Jean-Emmanuel Kurtz [France] ; Francesco Del Piano [France] ; J Xe9 R Xf4 Me Meunier [France] ; Nadia Raban [France] ; J Xe9 Rome Alexandre [France] ; Marie-Ange Mouret-Reynier [France] ; Isabelle Ray-Coquard [France] ; Magali Provansal Gross [France] ; Pierre-Emmanuel Brachet [France]Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
000018 (2022) Jean-David Fumet [France] ; Emilie Lardenois [France] ; Isabelle Ray-Coquard [France] ; Philipp Harter [Allemagne] ; Florence Joly [France] ; Ulrich Canzler [Allemagne] ; Caroline Truntzer [France] ; Olivier Tredan [France] ; Clemens Liebrich [Allemagne] ; Alain Lortholary [France] ; Daniel Pissaloux [France] ; Alexandra Leary [France] ; Jacobus Pfisterer [Allemagne] ; Alexandre Eeckhoutte [France] ; Felix Hilpert [Allemagne] ; Michel Fabbro [France] ; Christophe Caux [France] ; J Xe9 R Xf4 Me Alexandre [France] ; Aur Xe9 Lie Houlier [France] ; Jalid Sehouli [Allemagne] ; Emilie Sohier [France] ; Rainer Kimmig [Allemagne] ; Bertrand Dubois [France] ; Dominique Spaeth [France] ; Isabelle Treilleux [France] ; Jean-S Xe9 Bastien Frenel [France] ; Uwe Herwig [Allemagne] ; Olivia Le Saux [France] ; Nathalie Bendriss-Vermare [France] ; Andreas Du Bois [Allemagne]Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
000024 (2021) Candice Hober [France] ; Lisa Fredeau [France] ; Anne Pham-Ledard [France] ; Marouane Boubaya [France] ; Florian Herms [France] ; Philippe Celerier [France] ; Fran Xe7 Ois Aubin [France] ; Nathalie Beneton [France] ; Monica Dinulescu [France] ; Arnaud Jannic [France] ; Nicolas Meyer [France] ; Anne-B Xe9 N Xe9 Dicte Duval-Modeste [France] ; Laure Cesaire [France] ; Xc8 Ve-Marie Neidhardt [France] ; Xc9 Lodie Archier [France] ; Brigitte Dr Xe9 No [France] ; Candice Lesage [France] ; Cl Xe9 Mence Berthin [France] ; Nora Kramkimel [France] ; Florent Grange [France] ; Julie De Quatrebarbes [France] ; Pierre-Emmanuel Stoebner [France] ; Nicolas Poulalhon [France] ; Jean-Philippe Arnault [France] ; Safia Abed [France] ; Bertille Bonniaud [France] ; Sophie Darras [France] ; Valentine Heidelberger [France] ; Suzanne Devaux [France] ; Marie Moncourier [France] ; Laurent Misery [France] ; Sandrine Mansard [France] ; Maxime Etienne [France] ; Florence Brunet-Possenti [France] ; Caroline Jacobzone [France] ; Romain Lesbazeilles [France] ; Fran Xe7 Ois Skowron [France] ; Julia Sanchez [France] ; St Xe9 Phanie Catala [France] ; Mahtab Samimi [France] ; Youssef Tazi [France] ; Dominique Spaeth [France] ; Caroline Gaudy-Marqueste [France] ; Olivier Collard [France] ; Raoul Triller [France] ; Marc Pracht [France] ; Marc Dumas [France] ; Lucie Peuvrel [France] ; Pierre Combe [France] ; Olivier Lauche [France] ; Pierre Guillet [France] ; Yves Reguerre [France] ; Ingrid Kupfer-Bessaguet [France] ; David Solub [France] ; Am Xe9 Lie Schoeffler [France] ; Christophe Bedane [France] ; Ga Xeb Lle Qu Xe9 Reux [France] ; Sophie Dalac [France] ; Laurent Mortier [France] ; Xc8 Ve Maubec [France]Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
000028 (2020) Anne-Claire Hardy-Bessard [France] ; Fabien Brocard [France] ; Florian Clatot [France] ; Alain Lortholary [France] ; Beno Xee T You [France] ; Julien Grenier [France] ; J Xe9 R Xf4 Me Martin-Babau [France] ; Brigitte Lucas [France] ; J Xe9 R Xf4 Me Meunier [France] ; Jean-Marc Ferrero [France] ; Aude-Marie Savoye [France] ; Adina Marti [France] ; Raymond Despax [France] ; Isabelle Moullet [France] ; George Emile [France]First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study.
000034 (2020) Paul Sargos [France] ; Sylvie Chabaud [France] ; Igor Latorzeff [France] ; Nicolas Magn Xe9 [France] ; Ahmed Benyoucef [France] ; St Xe9 Phane Supiot [France] ; David Pasquier [France] ; Menouar Samir Abdiche [France] ; Olivier Gilliot [France] ; Pierre Graff-Cailleaud [France] ; Marlon Silva [France] ; Philippe Bergerot [France] ; Pierre Baumann [France] ; Yazid Belkacemi [France] ; David Azria [France] ; Meryem Brihoum [France] ; Michel Souli Xe9 [France] ; Pierre Richaud [France]Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
000035 (2019) Alice Cl Xe9 Ment-Zhao [France] ; Marie-Laure Tanguy [France] ; Paul Cottu [France] ; Brigitte De La Lande [France] ; Patrick Bontemps [France] ; Claire Lemanski [France] ; Pierre Baumann [France] ; Alexia Savignoni [France] ; Christelle Levy [France] ; Karine Peignaux [France] ; Agn Xe8 S Reynaud-Bougnoux [France] ; Aline Gobillion [France] ; Youlia Kirova [France]Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
000042 (2018) J B Bachet [France] ; O. Lucidarme [France] ; C B Levache [France] ; E. Barbier [France] ; J L Raoul [France] ; T. Lecomte [France] ; C. Desauw [France] ; F. Brocard [France] ; S. Pernot [France] ; G. Breysacher [France] ; J P Lagasse [France] ; F. Di Fiore [France] ; P L Etienne [France] ; O J M. Dupuis [France] ; A. Aleba [France] ; C. Lepage [France] ; J. Taieb [France]FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial.
000043 (2018) A. Dautruche [France] ; L. Belin [France] ; P. Cottu [France] ; P. Bontemps [France] ; C. Lemanski [France] ; B. De La Lande [France] ; P. Baumann [France] ; F. Missohou [France] ; C. L Xe9 Vy [France] ; K. Peignaux [France] ; A. Reynaud-Bougnoux [France] ; F. Denis [France] ; A. Gobillion [France] ; V. Pernin [France] ; Y. Kirova [France]Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study.
000046 (2017) Florence Joly [France] ; Aline Guillot [France] ; Yann-Alexandre Vano [France] ; Dominique Spaeth [France] ; Delphine Topart [France] ; Pascal Roffet [France] ; Rachid El Amarti [France] ; Ali Hasbini [France] ; Aude Fl Xe9 Chon [France][French national survey on incoming phone calls in oncology departments].
000050 (2017) P-E Heudel [France] ; M. Fabbro [France] ; C. Roemer-Becuwe [France] ; M C Kaminsky [France] ; A. Arnaud [France] ; F. Joly [France] ; S. Roche-Forestier [France] ; J. Meunier [France] ; C. Foa [France] ; B. You [France] ; F. Priou [France] ; Y. Tazi [France] ; A. Floquet [France] ; F. Selle [France] ; D. Berton-Rigaud [France] ; A. Lesoin [France] ; E. Kalbacher [France] ; A. Lortholary [France] ; L. Favier [France] ; I. Treilleux [France] ; I. Ray-Coquard [France]Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
000053 (2017) Florence Joly [France] ; Jean-Christophe Eymard [France] ; Laurence Albiges [France] ; Thierry Nguyen [France] ; Aline Guillot [France] ; Frederic Rolland [France] ; Dominique Spaeth [France] ; Brigitte Laguerre [France] ; Thierry Lebret [France] ; Nadia Kelkouli [France] ; Khemaies Slimane [France] ; Alain Ravaud [France]A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France.
000060 (2014) Victor Pernin [France] ; Lisa Belin [France] ; Paul Cottu [France] ; Patrick Bontemps [France] ; Claire Lemanski [France] ; Brigitte De La Lande [France] ; Pierre Baumann [France] ; Fernand Missohou [France] ; Christelle Levy [France] ; Karine Peignaux [France] ; Pierre Bougnoux [France] ; Fabrice Denis [France] ; Marc Bollet [France] ; R Xe9 Mi Dendale [France] ; Nora Ady Vago [France] ; Fran Xe7 Ois Campana [France] ; Alain Fourquet [France] ; Youlia M. Kirova [France]Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GentillyOncoV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegion.i -k "Région Normandie" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegion.i  \
                -Sk "Région Normandie" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GentillyOncoV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffRegion.i
   |clé=    Région Normandie
}}

Wicri

This area was generated with Dilib version V0.6.39.
Data generation: Thu Feb 8 07:40:56 2024. Site generation: Thu Feb 8 07:42:40 2024